|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-10
|
$284,744
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-09
|
$461,999
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
1P50CA217685-01
|
$1,732,856
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
5U01CA185148-03
|
$312,080
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$665,821
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016058-41S1
|
$139,874
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-41S2
|
$125,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-41S3
|
$200,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-41
|
$5,040,816
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
1R21CA215985-01
|
$198,000
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeted Nanotherapy for Pancreatic Cancer
|
5R01CA210192-02
|
$347,700
|
CHAUHAN, SUBHASH
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Juxtacrine regulation of metastasis from brain microenvironments
|
5K22CA181470-03
|
$195,990
|
CHEN, QING
|
WISTAR INSTITUTE
|
|
Precision nanotherapeutics for cancer treatment
|
1R01CA207584-01A1
|
$412,532
|
CHENG, JIANJUN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
|
5R01CA175480-05
|
$327,536
|
CHENG, ZHILIANG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles
|
1R43CA213538-01A1
|
$283,122
|
COLBY, AARON
|
IONIC PHARMACEUTICALS
|
|
Fred & Pamela Buffett Cancer Center Support Grant
|
5P30CA036727-31
|
$2,107,000
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$625,665
|
Dahut, William
|
CCR (NCI)
|
|
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
|
5R01CA182435-03
|
$344,269
|
DATTA, KAUSTUBH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Cancer Center Support Grant P30
|
3P30CA093373-15S1
|
$125,000
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-15S2
|
$89,478
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S1
|
$60,000
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S2
|
$75,000
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S1
|
$123,768
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S2
|
$75,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S3
|
$120,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S4
|
$50,000
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
5P30CA016672-42
|
$10,405,362
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN
|
5R01CA200263-02
|
$479,883
|
DOUGHERTY, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
|
1P01CA210961-01A1
|
$2,339,503
|
ESSERMAN, LAURA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA047904-29S1
|
$115,192
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-29S2
|
$55,932
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-29S3
|
$175,000
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-52S1
|
$137,250
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-52S2
|
$250,000
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-52S3
|
$125,000
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-52
|
$2,763,834
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Enhancement of BB2r-Targeted Radiotherapy for Prostate Cancer Utilizing Hypoxia-S
|
5R01CA179059-04
|
$312,288
|
GARRISON, JERED
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer
|
5R00CA166228-05
|
$249,000
|
GATZA, MICHAEL
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Epigenetically Reversing Paclitaxel Resistance in Triple Negative Breast Cancers
|
1F32CA210426-01A1
|
$61,866
|
GAYLE, SYLVIA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|